MicroRNA
Title:Meet the Associate Editor
Volume: 10 Issue: 1
Author(s): Wayne Tam
Affiliation:
Export Options
About this article
Cite this article as:
Tam Wayne , Meet the Associate Editor, MicroRNA 2021; 10 (1) . https://dx.doi.org/10.2174/221153661001210820092316
DOI https://dx.doi.org/10.2174/221153661001210820092316 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
2
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phosphodiesterase 3 (PDE3): Structure, Localization and Function
Cardiovascular & Hematological Agents in Medicinal Chemistry Improved Immunotoxins with Novel Functional Elements
Current Pharmaceutical Design Patent Perspective for Potential Antioxidant Compounds-Rutin and Quercetin
Recent Patents on Nanomedicine New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy
Current Drug Targets Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts
Current Cancer Drug Targets Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
Current Drug Metabolism Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy
Current Pharmaceutical Design Imatinib and Its Successors – How Modern Chemistry has Changed Drug Development
Current Pharmaceutical Design Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches
Anti-Cancer Agents in Medicinal Chemistry Autoimmune Neuromuscular Disorders
Current Neuropharmacology The Use of Growth Factors in Hematopoietic Stem Cell Transplantation
Current Pharmaceutical Design Cancer Therapy: Targeting Mitochondria and other Sub-cellular Organelles
Current Pharmaceutical Design The Role of B Cell Receptor Stimulation in CLL Pathogenesis
Current Pharmaceutical Design Anaerobic Bacteria as a Cause of Mycotic Aneurysm of the Aorta: Microbiology and Antimicrobial Therapy
Current Cardiology Reviews Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients
Current Pharmaceutical Design Diagnosis and Management of Lynch Syndrome
Recent Patents on Regenerative Medicine Induction of Synthetic Lethality by Natural Compounds Targeting Cancer Signaling
Current Pharmaceutical Design Arginine Deprivation as a Targeted Therapy for Cancer
Current Pharmaceutical Design